PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy. tbarbui@fondazionefrom.it.\', \'Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico \'A. Gemelli\' IRCCS, Rome, Italy.\', \'Hospital Clinic de Barcelona, Barcelona, Spain.\', \'Hematology Division, Foundation IRCCS Ca\' Granda Ospedale Maggiore Policlinico, Milan, Italy.\', \'FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.\', \'Spedali Civili, Brescia, Italy.\', \'Hematology Division and Bone Marrow Transplant, San Gerardo Hospital, ASST Monza, Monza, Italy.\', \'Hospital del Mar - IMIM, Barcelona, Spain.\', \'Hospital Universitario la Paz, Madrid, Spain.\', \'Hospital Saint-Louis, Paris, France.\', \'Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italia.\', \'AOU Città della Salute e della Scienza di Torino, Torino, Italy.\', \'Hospital Ramon y Cajal, IRYCIS, Madrid, Spain.\', \'Department of Hematology, Vall d\'Hebron Institute of Oncology (VHIO), Vall d\'Hebron Hospital Universitari, Vall d\'Hebron Barcelona Hospital Campus, C/ Natzaret, 115-117, 08035, Barcelona, Spain.\', \'Hospital Universitario Infanta Leonor, Madrid, Spain.\', \'Hospital General Universitario de Albacete, Albacete, Spain.\', \'Department of molecular medicine, University of Pavia, Pavia, Italy.\', \'Hospital Gregorio Maranon, Madrid, Spain.\', \'Hospital Clinico San Carlos, Madrid, Spain.\', \'Ospedale Policlinico \'G.B. Rossi\', Borgo Roma, Verona, Italy.\', \'Hospital Universitario de Mostoles, Madrid, Spain.\', \'ICO L\'Hospitalet-Hospital Moises Broggi, Sant Joan Despì, Barcelona, Spain.\', \'Hospital Universitario 12 de Octubre, Madrid, Spain.\', \'Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wrocław, Poland.\', \'IRCCS Ospedale San Raffaele, Milano, Italy.\', \'AOU Maggiore della Carità, Novara, Italy.\', \'Hospital Moncloa, Madrid, Spain.\', \'ICO Girona Hospital Josep Trueta, Girona, Spain.\', \'Hospital Universitario Principe de Asturias, Alcalà de Henares, Madrid, Spain.\', \'Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.\', \'Ospedale San Bortolo, Vicenza, Italy.\', \'Hospital Universitario de Burgos, Burgos, Spain.\', \'Hospital Clinico Universitario, INCLIVA, Valencia, Spain.\', \'Hospital General de Elche, Elche, Alicante, Spain.\', \'Institut Català d\'Oncologia-Hospital Germans Trias i Pujol, Joseo Carreras Leukemia Research Institute, Badalona (Barcelona) Spain, Universitat Autònoma de Barcelona, Barcelona, Spain.\', \'Center Research and Innovation of Myeloproliferative Neoplasms (CRIMM), Department of Experimental and Clinical Medicine, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.\', \'Guy\'s and St. Thomas\' NHS Foundation Trust, London, UK.\', \'ASST Papa Giovanni XXIII, Bergamo, Italy.\', \'Università degli Studi di Milano, Milano, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41408-021-00417-3
?:hasPublicationType
?:journal
  • Blood cancer journal
is ?:pmid of
?:pmid
?:pmid
  • 33563901
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.727
?:rankingScore_hIndex
  • 30
is ?:relation_isRelatedTo_publication of
?:title
  • Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all